Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INI-4001 |
Trade Name | |
Synonyms | INI 4001|INI4001 |
Drug Descriptions |
INI-4001 is a TLR7/8 agonist, which potentially enhances immune response (PMID: 38258117). |
DrugClasses | TLR7 Agonist 12 TLR8 Agonist 9 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + INI-4001 | Atezolizumab INI-4001 | 0 | 1 |
Avelumab + INI-4001 | Avelumab INI-4001 | 0 | 1 |
Cemiplimab + INI-4001 | Cemiplimab INI-4001 | 0 | 1 |
Durvalumab + INI-4001 | Durvalumab INI-4001 | 0 | 1 |
INI-4001 | INI-4001 | 0 | 1 |
INI-4001 + Nivolumab | INI-4001 Nivolumab | 0 | 1 |
INI-4001 + Pembrolizumab | INI-4001 Pembrolizumab | 0 | 1 |